Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page
GameStop CEO Ryan Cohen Targets $100 Billion Valuation With ‘Big’ Acquisition Plan: ‘Genius Or…Totally Foolish’

GameStop CEO Ryan Cohen Targets $100 Billion Valuation With ‘Big’ Acquisition Plan: ‘Genius Or…Totally Foolish’

by Namrata Sen | Jan 30, 2026 | General

GameStop Corp. (NYSE:GME) CEO Ryan Cohen unveiled his ambitious plan to transform the company into a $100 billion-plus giant. The CEO, in an interview with The Wall Street Journal on Thursday, stated that he plans to transform GameStop from an $11 billion company into...

Global Economy Headed For 2008-Style Meltdown In 2026? New Survey Warns AI-Fueled Leverage Could Trigger A Crisis

by Rishabh Mishra | Jan 30, 2026 | General

The Indian Economic Survey 2025-26 has outlined a stark warning regarding a potential global financial “systemic shock cascade” in 2026 that could outpace the severity of the 2008 Global Financial Crisis. The AI Infrastructure ‘Huge Bet’ Tabled in the Indian...

IBM, Blackstone, Cisco And An Energy Stock: CNBC’s ‘Final Trades’

by Avi Kapoor | Jan 30, 2026 | General

On CNBC’s “Halftime Report Final Trades,” Rob Sechan, CEO of NewEdge Wealth, said Blackstone Inc. (NYSE:BX) reported great results. On Thursday, Blackstone reported fourth-quarter results, with distributable earnings per share of $1.75 (+4% Y/Y), beating the...
This Southwest Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday

This Southwest Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday

by Avi Kapoor | Jan 30, 2026 | General

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Piper Sandler analyst John Barnidge upgraded Ameriprise...

Quince Therapeutics Stock Collapses After Key Trial Update In Rare Genetic Disease

by Vandana Singh | Jan 30, 2026 | General

Quince Therapeutics Inc. (NASDAQ:QNCX) on Thursday plunged almost 90% after the company shared topline results from its pivotal Phase 3 NEAT clinical trial evaluating its lead asset, dexamethasone sodium phosphate encapsulated in autologous erythrocytes (eDSP) for...
« Older Entries
Next Entries »

Recent Posts

  • OpenAI’s Engineering Lead Says AI Era Will Create Thousands Of Niche Startups: ‘It’s Hard For Me To Imagine…’
  • Trump Administration Moves Venezuela Oil Revenue From Qatar To US Treasury As Sales Top $1 Billion
  • Trump Could Order Potential Weeks-Long Military Operations Against Iran: Report
  • Trump Administration Promises Gateway Tunnel Funding After Missing Court-Ordered Deadline
  • Dan Ives Calls AI-Driven Software Selloff ‘Most Disconnected Trade,’ Says Salesforce And ServiceNow Are Historic Buys

Recent Comments

    Archives

    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.